F 
1,100
+0.27%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥47.44bn
FY2017FY2026
Net income
¥2.34bn
FY2017FY2026
Free cash flow
−¥839.2m
FY2017FY2026
Shareholders' equity
¥26.31bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥47.44bn | ¥45.64bn | ¥38.46bn | ¥32.38bn | ¥29.39bn | ¥28.54bn | ¥37.81bn | ¥36.90bn | ¥38.57bn | ¥36.09bn |
| Gross profit | ¥15.36bn | ¥14.83bn | ¥12.43bn | ¥10.53bn | ¥9.74bn | ¥9.09bn | ¥12.21bn | ¥11.75bn | ¥12.37bn | ¥11.59bn |
| Research and development | ¥115.4m | ¥164.4m | ¥168.0m | ¥160.0m | ¥184.4m | ¥238.4m | ¥449.5m | ¥116.9m | ¥193.2m | ¥160.3m |
| Operating income | ¥3.07bn | ¥3.20bn | ¥2.07bn | ¥1.12bn | ¥800.3m | ¥91.8m | ¥1.90bn | ¥2.06bn | ¥2.76bn | ¥2.22bn |
| Net income | ¥2.34bn | ¥2.27bn | ¥1.67bn | ¥992.6m | ¥649.6m | ¥15.6m | ¥1.11bn | ¥1.50bn | ¥1.97bn | ¥1.50bn |
| Diluted earnings per share | 178.84 | 172.92 | 127.74 | 75.73 | 49.56 | 1.19 | 84.64 | 114.15 | 149.94 | 114.67 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥45.86bn | ¥45.52bn | ¥41.62bn | ¥35.73bn | ¥34.44bn | ¥31.69bn | ¥35.88bn | ¥35.64bn | ¥35.41bn | ¥32.62bn |
| Cash and short-term investments | ¥7.65bn | ¥9.54bn | ¥8.44bn | ¥8.47bn | ¥9.34bn | ¥8.94bn | ¥9.13bn | ¥9.87bn | ¥9.28bn | ¥8.19bn |
| Total liabilities | ¥19.42bn | ¥21.10bn | ¥19.73bn | ¥15.62bn | ¥15.37bn | ¥13.20bn | ¥17.29bn | ¥17.39bn | ¥18.40bn | ¥17.60bn |
| Debt | ¥4.73bn | ¥5.03bn | ¥4.44bn | ¥3.68bn | ¥3.86bn | ¥3.83bn | ¥3.20bn | ¥3.71bn | ¥4.38bn | ¥4.61bn |
| Shareholders' equity | ¥26.31bn | ¥24.33bn | ¥21.89bn | ¥20.11bn | ¥19.07bn | ¥18.50bn | ¥18.58bn | ¥18.26bn | ¥17.02bn | ¥15.02bn |
| Shares outstanding | 13m | 13m | 13m | 13m | 13m | 13m | 13m | 13m | 13m | 13m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥944.4m | ¥3.14bn | ¥2.85bn | ¥290.5m | ¥2.60bn | ¥1.13bn | ¥1.22bn | ¥2.35bn | ¥2.30bn | ¥1.41bn |
| Capital spending | −¥1.78bn | −¥2.06bn | −¥1.44bn | −¥651.0m | −¥411.7m | −¥1.30bn | −¥946.2m | −¥846.5m | −¥579.3m | −¥1.20bn |
| Free cash flow | −¥839.2m | ¥1.08bn | ¥1.41bn | −¥360.6m | ¥2.19bn | −¥169.4m | ¥269.5m | ¥1.50bn | ¥1.72bn | ¥210.3m |
| Dividends paid | −¥589.8m | −¥511.1m | −¥288.3m | −¥262.1m | −¥262.1m | −¥262.1m | −¥262.1m | −¥262.1m | −¥163.8m | −¥131.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥10.95bn | ¥11.19bn | ¥13.29bn | ¥11.97bn | ¥10.33bn | ¥11.84bn | ¥12.54bn | ¥10.23bn |
| Gross profit | ¥3.70bn | ¥4.06bn | ¥4.24bn | ¥3.87bn | ¥3.64bn | ¥4.08bn | ¥4.15bn | ¥3.57bn |
| Operating income | ¥408.0m | ¥792.0m | ¥999.9m | ¥651.5m | ¥414.5m | ¥975.8m | ¥1.02bn | ¥689.6m |
| Net income | ¥2.20bn | ¥535.0m | ¥1.06bn | ¥315.9m | ¥265.4m | ¥705.2m | ¥850.2m | ¥422.9m |
| Diluted earnings per share | 167.86 | 40.82 | 80.68 | 24.11 | 20.25 | 53.81 | 64.87 | 32.26 |
| Total assets | ¥50.14bn | ¥48.27bn | ¥45.86bn | ¥44.53bn | ¥45.15bn | ¥44.57bn | ¥45.52bn | ¥42.95bn |
| Cash and short-term investments | ¥13.34bn | ¥8.23bn | ¥7.65bn | ¥5.93bn | ¥8.83bn | ¥6.80bn | ¥9.54bn | ¥7.62bn |
| Debt | ¥6.05bn | ¥2.53bn | ¥4.73bn | ¥1.05bn | ¥5.33bn | ¥1.04bn | ¥1.09bn | ¥1.12bn |
| Shareholders' equity | ¥28.89bn | ¥26.60bn | ¥26.31bn | ¥25.02bn | ¥24.81bn | ¥24.40bn | ¥24.33bn | ¥23.04bn |
Financial ratios
Data as of 1 Oct 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 32.4% | 32.5% | 32.3% | 32.5% | 33.1% | 31.8% |
| Operating margin | 6.5% | 7.0% | 5.4% | 3.5% | 2.7% | 0.3% |
| Net margin | 4.9% | 5.0% | 4.4% | 3.1% | 2.2% | 0.1% |
| Return on equity | 8.9% | 9.3% | 7.6% | 4.9% | 3.4% | 0.1% |
| Return on assets | 5.1% | 5.0% | 4.0% | 2.8% | 1.9% | 0.0% |
| Free cash flow yield | 17.3% | 33.1% | 27.3% | 6.0% | 19.1% | 15.5% |
| Revenue growth | 3.9% | 18.7% | 18.8% | 10.2% | 3.0% | -24.5% |
| Earnings growth | 3.4% | 35.4% | 68.7% | 52.8% | 4059.0% | -98.6% |
| Current ratio | 1.61x | 1.66x | 1.57x | 1.83x | 1.81x | 2.11x |
| Debt to equity | 0.18x | 0.21x | 0.20x | 0.18x | 0.20x | 0.21x |
| Equity ratio | 57.4% | 53.5% | 52.6% | 56.3% | 55.4% | 58.4% |
| Interest coverage | 63.56x | 73.90x | 77.46x | 43.19x | 28.29x | 3.44x |
| R&D as a share of sales | 0.2% | 0.4% | 0.4% | 0.5% | 0.6% | 0.8% |
| Buybacks as a share of market value | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 13.6% | 10.7% | 2.7% |
| Operating income | 40.0% | 101.8% | 6.8% |
| Net income | 33.2% | 172.4% | 13.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 32.4% | 32.4% | 32.4% | 32.1% |
| Operating margin | 6.7% | 5.8% | 4.7% | 5.1% |
| Net margin | 5.0% | 4.4% | 3.6% | 3.6% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 6.2 | 6.2 | 7.3 | 10.5 | 13.7 | — | 9.1 | 7.8 | 4.9 | 10.4 |
| Price to sales | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 32 years. Last went ex-dividend on 29 Dec 2025.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 80.00 | 24.00 | 22.00 | 20.00 | 40.00 | 20.00 | 20.00 | 12.50 |
- 2-for-1 split · 26 Sept 2018
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.